S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23/Type 3 Immunity. Silva de Melo BM, Veras FP, Zwicky P, Lima D, et al. J Invest Dermatol 2023;143:1678-1688.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Silva de Melo BM, Veras FP, Zwicky P, Lima D, et al. S100A9 Drives the Chronification of Psoriasiform Inflammation by Inducing IL-23/Type 3 Immunity. J Invest Dermatol 2023;143:1678-1688.
PMID: 36921684